Previous Article | Next Article 
Journal of Clinical Microbiology, September 1998, p. 2618-2622, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Phenotypic and Genotypic Characterization of
Clinical Strains of CDC Group IVc-2
Gerard J.
Osterhout,
Joan L.
Valentine, and
James D.
Dick*
Department of Pathology, Division of
Microbiology, Johns Hopkins Hospital, Baltimore, Maryland
21287-7093
Received 17 February 1998/Returned for modification 30 March
1998/Accepted 16 June 1998
 |
ABSTRACT |
CDC group IVc-2 is a gram-negative, oxidase-positive,
nonfermentative bacillus that has been implicated in human infections, including septicemia and peritonitis. Biochemically it most closely resembles Bordetella bronchiseptica and
Alcaligenes sp. Results of cellular fatty acid (CFA) and
16S rRNA gene analysis were combined with biochemical data to
assist in identification and classification. The predominant CFAs were
hexadecanoic acid (16:0), cis-9-hexadecanoic acid
(16:1
7c), cis-11-octadecanoic acid (18:1
7c), and
-cis-9,10-methylenehexadecanoic acid (17:0cyc). Small
amounts (2 to 5%) of 3-hydroxytetradecanoic acid (3-OH-14:0),
tetradecanoic acid (14:0), 2-hydroxyhexadecanoic acid (2-OH-16:0), and
-cis-11,12-methyleneoctadecanoic acid (19:0cyc) were
also consistently present. The highest 16S rRNA gene similarity was
with Ralstonia eutropha and Ralstonia
solanacearum. The CFA and 16S rRNA gene sequence data support the
inclusion of CDC group IVc-2 in the recently created genus
Ralstonia, which includes R. eutropha, R. pickettii, and R. solanacearum.
 |
INTRODUCTION |
CDC group IVc-2 is the vernacular
name for a group of asaccharolytic, gram-negative, nonfermentative
bacteria. The organism is found environmentally and is frequently
associated with contaminated water sources (2, 3, 11, 13).
Clinical cases of infection although rare, include 10 cases of
bacteremia (1, 4, 5, 12, 17) and 2 cases of peritonitis
(8, 25) in debilitated patients usually possessing
indwelling catheters. Only a single case of infection in a patient
lacking any predisposing pathologic condition has been reported
(13).
Biochemically, CDC group IVc-2 shares many features with
Bordetella avium, Bordetella bronchiseptica,
Oligella ureolytica (18), and Ralstonia
eutropha (formerly Alcaligenes eutrophus) (16). Cellular fatty acid (CFA) content, however, indicates a close association with the rRNA group II pseudomonads, which include Burkholderia cepacia, Ralstonia
pickettii (formerly Burkholderia pickettii), and
Ralstonia solanacearum (formerly Burkholderia solanacearum) (22). In order to facilitate
identification and to further clarify the taxonomic status of this
organism, we evaluated the results of biochemical, CFA, and 16S
rRNA gene sequence analysis.
 |
MATERIALS AND METHODS |
Conventional identification.
One reference strain (CDC
C6966) and four well-characterized stock clinical strains (JHH 1 to 4)
were analyzed in this study. All isolates were initially evaluated by
the following conventional tests: Gram stain, growth and morphologic
characteristics on trypticase soy agar with 5% sheep blood and
MacConkey agar, catalase, oxidase, triple sugar-iron agar reactions,
motility, indole production, gelatin liquefaction, utilization of
citrate, growth at 42°C, pigment production, oxidative-fermentative
(OF) carbohydrate utilization (glucose, xylose, and maltose),
utilization of sodium acetamide, decarboxylation of lysine, dihydrolase
reaction of arginine, urease activity, susceptibility to 10 µg of
colistin per ml, and hydrolysis of
o-nitrophenyl-
-D-galactopyranoside (ONPG).
Additional tests included acid production from 10% lactose;
phenylalanine deamination; nitrate reduction and gas production;
hydrolysis of esculin, starch, DNA, and phosphatidylcholine; allantoin
utilization; growth in the presence of 6.5% NaCl; and staining of
flagella. These tests were considered conventional identification
methods, as described by others (7, 22). Antibiotic
susceptibility was determined by the agar dilution method according to
National Committee for Clinical Laboratory Standards guidelines
(14).
Cellular fatty acid analysis.
Growth after 24 h from a
plate containing trypticase soy agar with 5% sheep blood was processed
for CFA analysis as previously described (15). Briefly,
fatty acids liberated from the saponified cells were derivatized to
form the corresponding fatty acid methyl esters (FAMEs) and then
extracted into a hexane-ether mixture. FAMEs were analyzed with a
Hewlett-Packard (Wilmington, Del.) 5890A gas chromatograph equipped
with a flame ionization detector, automatic sampler, integrator, and
computer. Separation of the FAMEs was achieved with a fused-silica
capillary column (25m by 0.2 mm) with cross-linked 5% phenylmethyl
silicone. The specific operating parameters for the instrument were
controlled and set automatically by the computer software.
Identification and quantitation of the FAME were performed by the
Microbial Identification System (MIS) software (Microbial ID, Newark,
Del.). Subsequent organism identification was based on computer
comparison of the unknown organism's FAME profile with that of
predetermined organism library profiles in the commercial database
(version 3.9). Library organism profiles were established on the basis
of a multivariate Gaussian model of at least 10 strains of each species
when possible. In addition to American Type Culture Collection strains,
well-characterized reference strains from a variety of environmental
sources are utilized to account for possible heterogeneity in the CFA
content.
The correlation of an unknown organism's profile with a library entry
is expressed as a similarity index (SI) on a numeric
scale of 0 to 1.0. SI values of >0.6 are considered excellent
matches, with a value of
0.5 representing approximately 3 standard
deviations from the library
profile mean.
Nucleic acid preparation.
Genomic DNA was Chelex extracted
(Sigma, St. Louis, Mo.) from several well-isolated bacterial colonies
by standard methods (20). The 16S rRNA gene was PCR
amplified with two universal primers, 5F and 1540R (PE Applied
Biosystems, Inc. [ABD], Foster City, Calif.), which are complementary
to the phylogenetically conserved regions of the 5' and 3' ends of the
16S rRNA gene, respectively. Bacterial DNA (100 ng) was amplified in
100 µl of master mix from the MicroSeq 16S rRNA gene kit (ABD, Foster
City, Calif.) and was amplified according to the manufacturer's
recommendations. The samples were subjected to 30 amplification cycles
consisting of 30 s of denaturation at 95°C, 30 s of
annealing at 60°C, and 45 s of extension at 72°C. An
additional elongation cycle of 10 min at 72°C allowed for complete,
final product extension. PCR product was confirmed by electrophoresis
of 10-µl reaction volumes in a 2% agarose gel containing ethidium
bromide. The remaining PCR products were purified by filtration with
Microcon 100 (Amicon, Beverly, Mass.) spin columns. Cycle sequencing
was subsequently performed with the PCR products with the sequencing
module from the MicroSeq 16S rRNA gene kit, which contains six forward
and six reverse sequencing primers (ABD). The sequencing mixture was purified of excess primers and unincorporated nucleotides by using Centri-Sep (Princeton Separations, Adelphia, N.J.) columns. The purified reaction product was dried under vacuum and resuspended in
deionized formamide-50 mM EDTA. Fluorescently labeled sequencing products were separated on an ABI PRISM 377 DNA sequencer (ABD) fitted
with a 5% polyacrylamide gel.
Nucleotide identification and signal processing were performed by the
Sequencing Analysis program, version 3.0. A consensus
sequence
generated with the AutoAssembler program was submitted
to the National
Center for Biotechnology Information (NCBI) GenBank
for sequence
alignment and to the Ribosome Database Project (RDP)
for similarity
ranking (
10). Identification with the MicroSeq
16S rDNA
database (ABD) was also evaluated. The MicroSeq 16S rDNA
database was
established from nearly complete 16S rRNA gene sequence
data derived
from the analysis of individual American Type Culture
Collection type
strains. For most species, the amplicon size is
1,527 bp. Currently
>1,100 eubacterial species are represented.
The unknown sequence was
subjected to an initial BLAST search
to limit the number of sequences
utilized in the more extensive
full-length alignment library search.
Similarity comparison results
are generated rapidly. Values are
expressed as percent sequence
difference from type strains.
A phylogenetic tree incorporating sequence data from the MicroSeq 16S
rDNA database was constructed by the neighbor-joining
algorithm
(
19) with the sequence data from
B. cepacia
being
used as the outgroup. Additional features of the MicroSeq
identification
and analysis software package enabled pairwise alignment
of all
the group IVc-2 strains and determination of sequence
similarity.
In particular, the concise alignment function depicts
positions
of nucleotide differences of unknown strains with library
entries.
Nucleotide sequence accession number.
The rRNA gene sequence
has been registered with the GenBank database under accession no.
AF067657.
 |
RESULTS |
All of the CDC group IVc-2 strains grew well aerobically after
24 h on MacConkey agar and Trypticase soy agar with 5% sheep blood at 37°C. By Gram staining and flagellar staining, the bacteria were short gram-negative rods possessing peritrichous flagella, respectively. The isolates were positive only for citrate
utilization, oxidase, catalase, and rapid urease production. In
contrast to phenotypically similar R. eutropha and
B. bronchiseptica, they failed to reduce nitrate or
nitrite. Additionally they were negative for indole production,
lysine decarboxylase, arginine dihydrolase, phenylalanine deamination,
and the ability to utilize allantoin or acetamide. They did not
hydrolyze esculin, gelatin, starch, DNA, ONPG, or phosphatidylcholine.
No acid production was detected from OF glucose, xylose, maltose, or
10% lactose. All reactions were held at least 14 days before being
assessed as negative.
Mean CFA values for the five strains are summarized in Table
1 and compared to reference profiles of
R. eutropha, B. cepacia, B. bronchiseptica, and R. pickettii. All of these
organisms share features either biochemically or in their CFA content
with group IVc-2. The CFA profile of group IVc-2 is notable for
possessing 16:1w7c and 16:0 as major acids; moderate amounts of
3-OH-14:0, 17:0cyc, and 18:1w7c; and trace to small amounts of
2-OH-16:1, 2-OH-18:1, 2-OH-14:0, 2-OH-16:0, and 19:0cyc11-12. The
complete profile is consistent with published results (22).
The overlap of the CFA profiles of Ralstonia,
Burkholderia, and group IVc-2 is easily demonstrated
compared to the MIS library database, since group IVc-2 was identified
with a low confidence value (SI) as either B. cepacia,
R. pickettii, or CDC group IVc-2. Additionally, it is common
to have enteric negative rods such as Enterobacter
aerogenes listed as possible choices. Strain C6966 was
identified as B. cepacia (SI, 0.440), followed by
Pantoea agglomerans (SI, 0.290) as the second choice. The
remaining four strains were all identified as B. cepacia (SI, <0.500), followed by either CDC group IVc-2,
Enterobacter cloacae (SI, <0.500), or R. pickettii (SI, <0.500) as the second choice.
All strains were resistant to ampicillin (>16 µg/ml), cefazolin
(>16 µg/ml), gentamicin (>8 µg/ml), tobramycin (>8 µg/ml), and
amikacin (>32 µg/ml). They were susceptible to tetracycline (2 µg/ml), ticarcillin (16 µg/ml), piperacillin (8 µg/ml),
cefuroxime (8 µg/ml), cefotaxime (2 µg/ml), ceftazidime (8 µg/ml), trimethoprim-sulfamethoxazole (0.5/9.5 µg/ml), and
ciprofloxacin (0.5 µg/ml). Similar results have been reported for
other strains of group IVc-2 (1, 17, 25).
Comparison of the consensus sequence for strain C6966 with sequences in
reference databases (RDP and GenBank) and the commercial database
(MicroSeq) is summarized in Tables
2 to
4. Comparable results were achieved with
the four clinical isolates. For each strain, R. eutropha or
Alcaligenes sp. strain M91-3 was the closest match, followed
by R. solanacearum and R. pickettii in each of the databases. The phylogenetic relationship between group IVc-2, R. eutropha, and R. solanacearum is further
illustrated in the evolutionary tree (Fig.
1). Group IVc-2 was most closely linked to R. eutropha, and as shown in Fig. 1, it exhibited
approximately 98% sequence similarity.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Phylogenetic tree derived from neighbor-joining (N Join)
analysis. B. cepacia was used as an outgroup. The
distance between two species is obtained by adding the lengths of the
connecting horizontal branches. Bar, 2.7% sequence difference.
|
|
Alignment of the 16S rRNA gene sequence for all group IVc-2
strains revealed >99.5% sequence similarity, while all strains yielded a >1.6% difference from the type strain of R. eutropha.
 |
DISCUSSION |
Recognition of CDC group IVc-2 in the clinical laboratory is
important, since it can cause serious infections and may be refractory to standard antibiotic regimens. This is particularly evident when
peritonitis develops as a complication of chronic ambulatory peritoneal
dialysis. Typical treatment consists of vancomycin and tobramycin, and
yet group IVc-2 isolates are resistant to both antibiotics. Prompt
identification would facilitate administration of the appropriate
therapy.
Among the nonfermentative gram-negative rods that do not oxidize
glucose, are oxidase positive, and are capable of growth on MacConkey
agar, group IVc-2 shares the most features with R. eutropha,
B. bronchiseptica, and O. ureolytica.
Nitrate reduction is an important differentiation characteristic, since
group IVc-2 is the only one of the organisms described above that is
usually negative for nitrate reductase. Only 11% of the strains have
been reported in the literature to be capable of reducing nitrate
(22). Like R. eutropha, B. bronchiseptica, and O. ureolytica, group IVc-2 is
conspicuous for rapid hydrolysis of urea, while B. avium is not. The lack of definitive phenotypic tests complicates
speciation when only physiological and biochemical features are
considered.
Identification of microorganisms by analysis of CFA composition has
become a routine method in many laboratories. Automation has enabled
reproducible results to be generated rapidly, provided the strains are
grown under specified standardized conditions. The CFA content of group
IVc-2 is most similar to those of B. cepacia and
R. pickettii, as reflected in the MIS identifications. For
all of the strains tested, B. cepacia was the first
choice, but at a low confidence value (SI, <0.500). The low SI value
and the presence of multiple choices reflect the inability of the MIS
system to definitively identify group IVc-2. However, the distinctive
pattern of rRNA group II pseudomonads together with enteric negative
rods necessitates the consideration of group IVc-2 as a probable
identification, even if group IVc-2 is not listed as a possibility.
Even though it is biochemically distinct, R. pickettii
possesses the closest overall composition, containing 16:1w7c, 16:0, and 18:1w7c as major acids, although with smaller amounts of
17:0cyc. The 17:0cyc content of group IVc-2 approaches that
of the rRNA group II organisms such as B. cepacia but differs quantitatively in the 16:1w7c and 19:0cyc
content and qualitatively by lacking 3-OH-16:0 and 2-OH-19:0cyc. Manual
inspection of the profile reveals both qualitative and
quantitative differences. Of the biochemically similar organisms,
only B. bronchiseptica and R. eutropha
are remotely related by CFAs. In addition to quantitative
differences, both lack 19:0cyc11-12 and the 2-OH-16:0 carbon
acids characteristic of group IVc-2, B. cepacia, and
R. pickettii.
The combination of CFA and biochemical data is generally sufficient for
accurate identification of group IVc-2. CFA analysis can be utilized as
a rapid screening method followed by select biochemical tests to
confirm the identification. When phenotypic methods prove inconclusive,
confirmatory genotypic techniques such as 16S rRNA gene sequence
analysis are beneficial.
Each of the databases searched in this study indicated that the group
IVc-2 sequences showed the highest similarity to that of R. eutropha. However, the relatively low scores suggested the existence of a distinct species. Typically, two organisms are assumed to belong to the same species if they possess less than 5 to 15 nucleotide differences in their 16S rRNA gene sequences (6). The MicroSeq 16S rDNA database clearly depicts the
close, yet distinct, relatedness to R. eutropha
(1.6%), because a total of 25 bp differences are present (Table
5).
View this table:
[in this window]
[in a new window]
|
TABLE 5.
Nucleotide position differences among CDC group IVc-2
strains and the type strain of R. eutropha, ATCC 17697
|
|
Among the available methods for evaluating phylogenetic relationships,
chemotaxonomic and genotypic techniques are being utilized with
increasing frequency (21). Two groups of macromolecules that
have recently been made amenable to simplified analysis are CFA and
rRNAs. Analysis of the 16S rRNA gene sequence has proven to be most
useful in molecular systematics, since it is highly conserved,
universally distributed, and contains diagnostically significant
variable regions.
Polyphasic studies combining phenotypic characteristics,
DNA-DNA and DNA-rRNA hybridization, lipid composition, and
16S rRNA gene sequence have been used to redefine the rRNA group II
pseudomonads (23). The genetic bifurcation in this group has
been further established (9), with the genus
Ralstonia being proposed to accommodate one subdivision
(24). In addition to R. pickettii and R. solanacearum, phenotypically dissimilar R. eutropha has been included because of the high levels of 16S rRNA gene sequence similarities.
CDC group IVc-2 is an organism phenotypically similar to R. eutropha. The results of this study indicate a high level of
genotypic similarity as well and warrant the inclusion of this
organism in the genus Ralstonia. Since the RDP
Similarity Ranking and NCBI GenBank BLAST searches provide
only reasonable approximations of phylogenetic analysis, further
tests, such as cellular lipid analysis, DNA-DNA hybridization,
and determination of the mole percent G+C, would be useful for
confirmation. Further clarification of the taxonomic status would also
be helpful in recognizing this organism in the clinical
laboratory, since it can be a source of serious infection in
immunocompromised patients. Traditionally, the technical
complexity and laborious nature of 16S rRNA gene sequence
analysis have limited its applications as a routine diagnostic tool.
However, approaches to automate and standardize this methodology should
facilitate its implementation as a common laboratory protocol.
 |
ACKNOWLEDGMENTS |
We thank the following staff of PE/Applied Biosystems and MIDI
Labs for training and technical support: Nicole Ellis, Deborah Dodge,
Scott Anderson, Doug Smith, Stacey Montgomery, Mike Waddington, John
Bartel, Maggie Riehman, and Myron Sasser.
We give special thanks to PE/Applied Biosystems for equipment and
support material.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, Division of Microbiology, Meyer B1-193, Johns Hopkins
Hospital, 600 North Wolfe St., Baltimore, MD 21287-7093. Phone: (410)
955-5077. Fax: (410) 614-8087. E-mail:
jdick{at}pathlan.path.jhu.edu.
 |
REFERENCES |
| 1.
|
Anderson, R. R.,
P. Warnick, and P. C. Schreckenberger.
1997.
Recurrent CDC group IVc-2 bacteremia in a human with AIDS.
J. Clin. Microbiol.
35:780-782[Abstract].
|
| 2.
|
Aspinall, S. T., and R. Graham.
1989.
Two sources of contamination of a hydrotherapy pool by environmental organisms.
J. Hosp. Infect.
14:285-292[Medline].
|
| 3.
|
Clark, W. A.,
D. G. Hollis,
R. E. Weaver, and P. Riley.
1984.
Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria.
Centers for Disease Control, Atlanta, Ga.
|
| 4.
|
Crowe, H. M., and S. M. Brecher.
1987.
Nosocomial septicemia with CDC group IV c-2, an unusual gram-negative bacillus.
J. Clin. Microbiol.
25:2225-2226[Abstract/Free Full Text].
|
| 5.
|
Dan, M.,
S. A. Berger,
D. Aderka, and Y. Levo.
1986.
Septicemia caused by the gram-negative bacterium CDC IV c-2 in an immunocompromised human.
J. Clin. Microbiol.
23:803[Abstract/Free Full Text].
|
| 6.
|
Fox, G. E.,
J. D. Wisotzkey, and P. Jurtshuk, Jr.
1992.
How close is close: 16S rRNA sequence identity may not be sufficient to guarantee species identity.
Int. J. Syst. Bacteriol.
42:166-170[Abstract/Free Full Text].
|
| 7.
|
Gilardi, G. L. (ed.).
1985.
Nonfermentative gram-negative rods, p. 17-84.
Marcel Dekker, Inc., New York, N.Y.
|
| 8.
|
Hansen, W., and Y. Glupczynski.
1985.
Group IVc-2-associated peritonitis.
Clin. Microbiol. Newsl.
7:43-44.
|
| 9.
|
Li, X.,
M. Dorsch,
T. Del Dot,
L. I. Sly,
E. Stackebrandt, and A. C. Hayward.
1993.
Phylogenetic studies of the rRNA group II pseudomonads based on 16S rRNA gene sequences.
J. Appl. Bacteriol.
74:324-329.
|
| 10.
|
Maidak, B. L.,
G. J. Olsen,
N. Larsen,
R. Overbeek,
M. J. McCaughey, and C. R. Woese.
1996.
The Ribosomal Database Project (RDP).
Nucleic Acids Res.
24:82-85[Abstract/Free Full Text].
|
| 11.
|
Mania, C. M.,
O. C. Nunes,
P. V. Morais, and M. S. da Costa.
1990.
Heterotrophic plate counts and the isolation of bacteria from mineral waters on selective and enrichment media.
J. Appl. Bacteriol.
69:871-876[Medline].
|
| 12.
|
Moissenet, D.,
M.-D. Tabone,
J.-P. Girardet,
G. Leverger,
A. Garbarg-Chenon, and H. Vu-Thien.
1996.
Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysis.
J. Clin. Microbiol.
34:1264-1266[Abstract].
|
| 13.
|
Musso, D.,
M. Drancourt,
J. Bardot, and R. Legré.
1994.
Human infection due to the CDC group IVc-2 bacterium: case report and review.
Clin. Infect. Dis.
18:482-484[Medline].
|
| 14.
|
National Committee for Clinical Laboratory Standards.
1993.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 15.
|
Osterhout, G. J.,
V. H. Shull, and J. D. Dick.
1991.
Identification of clinical isolates of gram-negative nonfermentative bacteria by an automated cellular fatty acid identification system.
J. Clin. Microbiol.
29:1822-1830[Abstract/Free Full Text].
|
| 16.
|
Pickett, M. J., and J. R. Greenwood.
1986.
Identification of oxidase-positive, glucose-negative, motile species of nonfermentative bacilli.
J. Clin. Microbiol.
23:920-923[Abstract/Free Full Text].
|
| 17.
|
Ramos, J. M.,
F. Soriano,
M. Bernacer,
J. Esteban, and J. Zapardiel.
1993.
Infection caused by the nonfermentative gram-negative bacillus CDC group IVc-2: case report and literature review.
Eur. J. Clin. Microbiol. Infect. Dis.
12:456-458[Medline].
|
| 18.
|
Rossau, R.,
K. Kersters,
E. Falsen,
E. Jantzen,
P. Segers,
A. Union,
L. Nehis, and J. Deley.
1987.
Oligella, a new genus including Oligella urethralis comb. nov. (formerly Moraxella urethralis) and Oligella ureolytica sp. nov. (formerly CDC group IVe): relationship to Taylorella equigenitalis and related taxa.
Int. J. Syst. Bacteriol.
37:198-210[Abstract/Free Full Text].
|
| 19.
|
Saitou, N., and M. Nei.
1987.
The neighbor-joining method: a new method for reconstructing phylogenetic trees.
Mol. Biol. Evol.
4:406-425[Abstract].
|
| 20.
|
Singer-Sam, J.,
R. L. Tanguay, and A. D. Riggs.
1989.
Use of Chelex to improve the PCR signal from a small number of cells. Amplifications, no. 3.
Perkin-Elmer Cetus, Norwalk, Conn.
|
| 21.
|
Vandamme, P.,
B. Pot,
M. Gillis,
P. De Vos,
K. Kersters, and J. Swings.
1996.
Polyphasic taxonomy, a consensus approach to bacterial systematics.
Microbiol. Rev.
60:407-438[Abstract/Free Full Text].
|
| 22.
|
Weyant, R. S.,
C. W. Moss,
R. E. Weaver,
D. G. Hollis,
J. G. Jorda,
E. C. Cook, and M. I. Daneshvar.
1996.
Identification of unusual pathogenic Gram-negative aerobic and facultatively anaerobic bacteria, 2nd ed.
Williams & Wilkins, Baltimore, Md.
|
| 23.
|
Yabuuchi, E.,
Y. Kosako,
H. Oyaizu,
I. Yano,
H. Hotta,
Y. Hashimoto,
T. Ezaki, and M. Arakawa.
1992.
Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.
Microbiol. Immunol.
36:1251-1275[Medline].
|
| 24.
|
Yabuuchi, E.,
Y. Kosako,
I. Yano,
H. Hotta, and Y. Nishiuchi.
1995.
Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. nov.: proposal of Ralstonia pickettii (Ralston, Palleroni and Doudoroff 1973) comb. nov., Ralstonia solanacearum (Smith 1896) comb. nov. and Ralstonia eutropha (Davis 1969) comb. nov.
Microbiol. Immunol.
39:897-904[Medline].
|
| 25.
|
Zapardiel, J.,
G. Blum,
C. Caramelo,
R. Fernandez-Roblas,
J. L. Rodriguez-Tudela, and F. Soriano.
1991.
Peritonitis with CDC group IVc-2 bacteria in a patient on continuous ambulatory peritoneal dialysis.
Eur. J. Clin. Microbiol. Infect. Dis.
10:509-511[Medline].
|
Journal of Clinical Microbiology, September 1998, p. 2618-2622, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vaneechoutte, M., Kampfer, P., De Baere, T., Falsen, E., Verschraegen, G.
(2004). Wautersia gen. nov., a novel genus accommodating the phylogenetic lineage including Ralstonia eutropha and related species, and proposal of Ralstonia [Pseudomonas] syzygii (Roberts et al. 1990) comb. nov.. Int. J. Syst. Evol. Microbiol.
54: 317-327
[Abstract]
[Full Text]
-
Zhou, N.-Y., Fuenmayor, S. L., Williams, P. A.
(2001). nag Genes of Ralstonia (Formerly Pseudomonas) sp. Strain U2 Encoding Enzymes for Gentisate Catabolism. J. Bacteriol.
183: 700-708
[Abstract]
[Full Text]
-
Moissenet, D., Bidet, P., Garbarg-Chenon, A., Arlet, G., Vu-Thien, H.
(2001). Ralstonia paucula (Formerly CDC Group IV c-2): Unsuccessful Strain Differentiation with PCR-Based Methods, Study of the 16S-23S Spacer of the rRNA Operon, and Comparison with Other Ralstonia Species (R. eutropha, R. pickettii, R. gilardii, and R. solanacearum). J. Clin. Microbiol.
39: 381-384
[Abstract]
[Full Text]
-
Moissenet, D., Goujon, C. P., Garbarg-Chenon, A., Vu-Thien, H.
(1999). CDC Group IV c-2: a New Ralstonia Species Close to Ralstonia eutropha. J. Clin. Microbiol.
37: 1777-1781
[Abstract]
[Full Text]